Replies to post #3477 on Galectin Therapeutics Inc. (GALT)

[buckysherm]

GRMD02 improves Keytruda effectiveness by 4 times !
GALT published Keytruda head & neck 16% ORR, Complete response 5%, with GR-MD-02 67% and 33%.